Back to Structural Heart

Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Adverse Events: FDA MAUDE Data

Edwards Lifesciences LLC · Transcatheter Aortic Valve (TAVR) · First cleared Dec 2018 · 3 device variants grouped

Total Reports

13,813

Reports (30d)

194

Active Signals

2

Open Recalls

0

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Severe Stenosis and Heart Failure Symptoms

ultra, specialist, sapien ultra, resilia valve, ultra resilia

339

reports

2

Valve Explantation Four Years Post-Implant

aortic position, registry, sapien ultra, months, explanted

88

reports

3

Literature Batch: Self-Expanding Valve Outcomes

devices, evolut, patients, study, included

6

reports

4

Death Post-Implant in Registry Data

registry, sapien ultra, resilia valve, ultra resilia, ultra

1

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

Increasing trendcriticalVolume spikehigh

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.